tiprankstipranks
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market

Nautilus Biotechnolgy (NAUT) Income Statement

Compare
127 Followers

Nautilus Biotechnolgy Income Statement

Last quarter (Q3 2024), Nautilus Biotechnolgy's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Nautilus Biotechnolgy's net income was $-16.45M. See Nautilus Biotechnolgy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -5.71M$ -3.42M$ -2.84M$ -2.35M$ 0.00
Operating Expenses
$ 76.15M$ 63.62M$ 50.50M$ 15.74M$ 9.62K
Depreciation and Amortization
$ 1.85M$ 3.42M$ 2.84M$ 2.35M$ 548.00K
EBITDA
$ -74.30M$ -54.51M$ -47.47M$ -13.27M$ -9.56M
Operating Income
$ -76.15M$ -63.62M$ -50.50M$ -15.74M$ -10.11K
Other Income/Expenses
$ 12.48M$ 5.69M$ 183.00K$ 125.00K$ -9.61M
Pretax Income
$ -63.67M$ -57.92M$ -50.31M$ -15.62M$ -9.62K
Net Income
$ -63.67M$ -63.74M$ -50.31M$ -15.62M$ -9.62K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.51$ -0.51$ -0.60$ -0.52$ 0.00
Diluted EPS
$ -0.51$ -0.51$ -0.60$ -0.52$ 0.00
Weighted Average Shares Outstanding
124.92M 124.59M 84.46M 29.96M 7.19M
Weighted Average Shares Outstanding (Diluted)
124.92M 124.59M 84.46M 29.96M 7.19M
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis